Skip to content

Change in AR at other companies

Opko Health logo
Opko HealthOPK
-$9.53M+58.5%
AMP
Amphastar PharmaceuticalsAMPH
$4.55M-43.7%
HRO
HarrowHROW
-$9.83M+74.9%
Precigen logo
PrecigenPGEN
$22.49M+12,950%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$5.56M+826%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$19M-90.0%

Other financials

Income statement

See full
Revenue$58.3M+104%
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$824.68M+13.4%
Enterprise value$810.08M+12.7%
P/S-4.9×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
Net margin-76.8%-34.5pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s change in AR?
Phathom Pharmaceuticals, Inc. (PHAT) reported change in AR of $2.6M in Q1 2026.
How has Phathom Pharmaceuticals, Inc.'s change in AR changed year-over-year?
Phathom Pharmaceuticals, Inc.'s change in AR increased by 206.7% year-over-year, from -$2.43M to $2.6M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.